Crystal structure of Streptococcus pyogenes EndoS, an immunomodulatory endoglycosidase specific for human IgG antibodies

Proceedings of the National Academy of Sciences of the United States of America

Volumn 111, Issue 18, 2014, Pages 6714-6719

  Trastoy, Beatriz ^a   Lomino, Joseph V ^a   Pierce, Brian G ^b   Carter, Lester G ^c   Günther, Sebastian ^a   Giddens, John P ^a   Snyder, Greg A ^a   Weiss, Thomas M ^c   Weng, Zhiping ^b   Wang, Lai Xi ^a   Sundberg, Eric J ^a  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^c SLAC NATIONAL ACCELERATOR LABORATORY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ENDOGLYCOSIDASE ENDOS; GLYCOSIDASE; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN G1; UNCLASSIFIED DRUG;

ARTICLE; BIOTECHNOLOGY; CONTROLLED STUDY; CRYSTAL STRUCTURE; ENZYME ACTIVITY; ENZYME SPECIFICITY; ENZYME STRUCTURE; HYDROLYSIS; NONHUMAN; OLIGOMERIZATION; PRIORITY JOURNAL; STREPTOCOCCUS PYOGENES;

BACTERIAL PROTEINS; CATALYTIC DOMAIN; CRYSTALLOGRAPHY, X-RAY; GLYCOSIDE HYDROLASES; HUMANS; IMMUNOGLOBULIN FC FRAGMENTS; IMMUNOGLOBULIN G; IMMUNOLOGIC FACTORS; MODELS, MOLECULAR; PROTEIN CONFORMATION; PROTEIN STRUCTURE, TERTIARY; SCATTERING, SMALL ANGLE; STREPTOCOCCUS PYOGENES; SUBSTRATE SPECIFICITY; X-RAY DIFFRACTION;

EID: 84899805399     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1322908111     Document Type: Article

References (38)

1. Col lin M, Olsén A (2003) Extracellular enzymes with immunomodulating activities: Variations on a theme in Streptococcus pyogenes. Infect Immun 71(6):2983-2992.
2. Ling Z, et al. (2009) The X-ray crystal structure of an Arthrobacter protophormiae endo-beta-N-acetylglucosaminidase reveals a (beta/alpha)(8) catalytic domain, two ancillary domains and active site residues key for transglycosylation activity. J Mol Biol 389(1):1-9.
3. Yin J, et al. (2009) Structural basis and catalytic mechanism for the dual functional endo-beta-N-acetylglucosaminidase A. PLoS ONE 4(3):e4658.
4. Abbott DW, M acauley MS, Vocadlo DJ, Boraston AB (2009) Streptococcus pneumoniae endohexosaminidase D, structural and mechanistic insight into substrate-assisted catalysis in family glycoside hydrolases. J Biol Chem 284(17):11676-11689.
5. Van Roey P, Rao V, Plummer TH, Jr., Tarentino AL (1994) Crystal structure of endobeta-N-acetylglucosaminidase F1, an alpha/beta-barrel enzyme adapted for a complex subst rate. Biochemistry 33(47):13989-13996.
6. Waddling CA, Plummer TH, Jr., Tarentino AL, Van Roey P (2000) Structural basis for the substrate specificity of endo-beta-N-acetylglucosaminidase F(3). Biochemistry 39(27):7878-7885.
7. Rao V, Guan C, Van Roey P (1995) Crystal structure of endo-beta-N-acetylglucosaminidase H at 1.9 A resolution: Active-site geometry and substrate recognition. Structure 3(5):449-457.
8. Collin M, Olsén A (2001) EndoS, a novel secreted protein from Streptococcus pyogenes with endoglycosidase activity on human IgG. EMBO J 20(12):3046-3055.
9. Collin M, Olsén A (2001) Effect of SpeB and EndoS from Streptococcus pyogenes on human immunoglobulins. Infect Immun 69(11):7187-7189.
10. Collin M, et al. (2002) EndoS and SpeB from Streptococcus pyogenes inhibit immunoglobulin-mediated opsonophagocytosis. Infect Immun 70(12):6646-6651.
11. Albert H, Collin M, Dudziak D, Ravetch JV, Nimmerjahn F (2008) In vivo enzymatic modulation of IgG glycos ylation inhibits autoimmune disease in an IgG subclassdependent manner. Proc Natl Acad Sci USA 105(39):15005-15009.
12. Arnold JN, Wormald MR, Sim RB, Rudd PM, Dwek RA (2007) The impact of glycosy lation on the biological function and structure of human immunoglobulins. Annu Rev Immunol 25:21-50.
13. Lund J, Takahashi N, Pound JD, Goodall M, Jefferis R (1996) Multiple interactions of I gG with its core oligosaccharide can modulate recognition by complement and human Fc gamma receptor I and influence the synthesis of its oligosaccharide chains. J Immunol 157(11):4963-4969.
14. Krapp S, Mimu ra Y, Jefferis R, Huber R, Sondermann P (2003) Structural analysis of human IgG-Fc glycoforms reveals a correlation between glycosylation and structural integrity. J Mol Biol 325(5):979-989.
15. Nimmerjahn F, Ravetch JV (2008) Fcgamma receptors as regulators of immune responses. Nat Rev Immunol 8(1):34-47.
16. Nandakumar KS, et al. (2007) Endoglycosidase treatment abrogates IgG arthritogenicity: Importance of IgG glycosylation in arthritis. Eur J Immunol 37(10):2973-2982.
17. Collin M, Shannon O, Björck L (2008) IgG glycan hydrolysis by a bacterial enzyme as a therapy against autoimmune conditions. Proc Natl Acad Sci USA 105(11):4265-4270.
18. van Timmeren MM et al 2010 IgG glycan hydrolysis attenuates ANCA-mediated glomerulonephritis J Am Soc Nephrol 21 7 1103-1114
19. Allhorn M, et al. (2010) The IgG-specific endoglycosidase EndoS inhibits both cellular and complement-mediated autoimmune hemolysis. Blood 115(24):5080-5088.
20. Tradtrantip L, Ratelade J, Zhang H, Verkman AS (2013) Enzymatic deglycosylation converts pathogenic neuromyelitis optica anti-aquaporin-4 immunoglobulin G into therapeutic antibody. Ann Neurol 73(1):77-85.
21. Hirose M, et al. (2012) Enzymatic autoantibody glycan hydrolysis alleviates autoimmunity against type VII collagen. J Autoimmun 39(4):304-314.
22. Lood C, et al. ( 2012) IgG glycan hydrolysis by endoglycosidase S diminishes the proinflammatory properties of immune complexes from patients with systemic lupus erythematosus: A possible new treatment Arthritis Rheum 64(8):2698-2706.
23. Baruah K, et al. (2012) Selective deactivation of serum IgG: A general strategy for the enhancement of monoclonal antibody receptor interactions. J Mol Biol 420(1 -2):1-7.
24. W ang L-X (2008) Chemoenzymatic synthesis of glycopeptides and glycoproteins through endoglycosidase-catalyzed transglycosylation. Carbohydr Res 343(10-11): 1509-1522.
25. Rudd PM, et al. (1994) Glycoforms modify the dynamic stability and functional activity of an enzyme. Biochemistry 33(1):17-22.
26. Umana P, Jean-Mairet J, Moudry R, Amstutz H, Bailey JE (1999) Engine ered glycoforms of an antineuroblastoma IgG1 with optimized antibody-dependent cellular cytotoxic activity. Nat Biotechnol 17(2):176-180.
27. Yamane-Ohnuki N, et al. (2004) Establishment of FUT8 kno ckout Chinese hamster ovary cells: An ideal host cell line for producing completely defucosylated antibodies with enhanced antibody-dependent cellular cytotoxicity. Biotechnol Bioeng 87(5): 614-622.
28. Wang LX, Lomino JV (2012) Emerging technologies for making glycan-defined glycoproteins. ACS Chem Biol 7(1):110-122.
29. Goodfellow JJ, et al. (2012) An endoglycosidase with alternative glycan specificity allows broadened glycoprotein remodelling. J Am Chem Soc 134(19):8030-8033.
30. Huang W, Giddens J, Fan SQ, Toonstra C, Wang LX (2012) Chemoenzymatic glycoengineering of intact IgG antib odies for gain of functions. J Am Chem Soc 134(29): 12308-12318.
31. Svergun D, et al. (1995) CRYSOL -Evaluation of the solution scattering from macromolecules with known atomic srtructure and fitting to experimental data. J Appl Cryst 28:768-773.
32. Holm L, Rosenström P (2010) Dali server: Conservation mapping in 3D. Nucleic Acids Res 38(Web Server issue):W545-W549.
33. Allhorn M, Olsén A, Collin M (2008) EndoS from Streptococcus pyogenes is hydrolyzed by the cysteine proteinase SpeB and requires glutamic acid 235 and tryptophans for IgG glycan-hydrolyzing activity. BMC Microbiol 8:3.
34. Allhorn M, Olin AI, Nimmerjahn F, Collin M (2008) Human IgG/Fc gamma R interactions are modulated by streptococcal IgG glycan hydrolysis. PLoS ONE 3(1):e1413.
35. Pi erce BG, Hourai Y, Weng Z (2011) Accelerating protein docking in ZDOCK using an advanced 3D convolution library. PLoS ONE 6(9):e24657.
36. Emekli U, Schneidman-Duhovny D,Wolfson HJ, Nussinov R, Haliloglu T (2008) HingeProt: Automated prediction of hinges in protein structures. Proteins 70(4):1219-1227.
37. Trastoy B, Lomino JV, Wang L-X, Sundberg EJ (2013) Liquid-liquid diffusion crystallization improves the X-ray diffraction of EndoS, an endo-N-acetylglucosaminidase from Streptococcus pyogenes with activity on human Ig G. Acta Crystallogr Sect F Struct Biol Cryst Commun 69(Pt 12):1405-1410.
38. Kortemme T, Baker D (2002) A simple physical model for binding energy hot spots in protein-protein complexes. Proc Natl Acad Sci USA 99(22):14116-14121.